BALAXI PHARMACEUTICALS LIMITED (BALAXI) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE618N01022
Key metrics
- Market Cap
- ₹124 Cr
- P/E Ratio
- 86.15
- EPS
- 0.26
- Book Value
- 45.12
- P/B Ratio
- 0.5
- ROE
- 0.57%
- ROCE
- 2.08%
- Debt / Equity
- 0.23
- Net Margin
- 0.52%
- Revenue Growth
- -7.65%
- Profit Growth
- -94.35%
- Dividend Yield
- —
- 52W High
- ₹47.88
- 52W Low
- ₹15.20
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About BALAXI PHARMACEUTICALS LIMITED
Balaxi Pharmaceuticals Limited engages in the international wholesale distribution of pharmaceuticals, builders hardware, and FMCG products in India, Africa, and Latin America. The company offers pharmaceutical products across various therapeutic areas, including antibiotics, analgesic, anti-malaria, and others. It also provides biscuits and toothpaste. The company was formerly known as Balaxi Ventures Limited and changed its name to Balaxi Pharmaceuticals Limited in October 2020. The company was incorporated in 1942 and is headquartered in Hyderabad, India. Balaxi Pharmaceuticals Limited is a subsidiary of Balaxi Overseas Private Limited.
- Headquarters
- Hyderabad, India
The full BALAXI PHARMACEUTICALS LIMITED analysis
Create a free account to open the complete BALAXI deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.